Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.44 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.44 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 7/20 | 0.38 |
| ▸ | CES1 | P23141 | 5/20 | 0.38 |
| ▸ | GGPS1 | O95749 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | FDPS | P14324 | 4/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17830486 | 1.00 | CES2 (0.44) | CES2LPAR1LPAR3LMNAHSD17B10 | |
| SCHEMBL17830477 | 1.00 | CES2 (0.44) | CES2LPAR1LPAR3LMNAHSD17B10 | |
| SCHEMBL17830472 | 1.00 | CES2 (0.44) | CES2LPAR1LPAR3LMNAHSD17B10 | |
| SCHEMBL17830527 | 1.00 | CES2 (0.44) | CES2LPAR1LPAR3LMNAHSD17B10 | |
| SCHEMBL17830617 | 0.98 | CES2 (0.42) | CES2LPAR1LPAR3LMNAHSD17B10 | |
| SCHEMBL17830674 | 0.98 | CES2 (0.42) | CES2LPAR1LPAR3LMNAHSD17B10 | |
| SCHEMBL17830613 | 0.98 | CES2 (0.42) | CES2LPAR1LPAR3LMNAHSD17B10 | |
| SCHEMBL17830669 | 0.98 | CES2 (0.42) | CES2LPAR1LPAR3LMNAHSD17B10 | |
| SCHEMBL17830630 | 0.98 | CES2 (0.42) | CES2LPAR1LPAR3LMNAHSD17B10 | |
| SCHEMBL17830666 | 0.98 | CES2 (0.42) | CES2LPAR1LPAR3LMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9850428-B2 | Compound having poly (difluoromethylene) chain, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2017-12-26 | — | — | US | disclosed |
| US-9850428-B2 | Compound having poly (difluoromethylene) chain, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2017-12-26 | — | — | US | disclosed |
| US-20160168466-A1 | COMPOUND HAVING POLY (DIFLUOROMETHYLENE) CHAIN, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2016-06-16 | — | — | US | disclosed |
| US-20160168466-A1 | COMPOUND HAVING POLY (DIFLUOROMETHYLENE) CHAIN, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160168466-A1 | COMPOUND HAVING POLY (DIFLUOROMETHYLENE) CHAIN, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | CXCR1, F12, C1S | CES2 1645/4885LPAR1 62/4885LPAR3 330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.